Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

3.98
+0.18004.74%
Post-market: 3.97-0.0101-0.25%18:37 EST
Volume:883.69K
Turnover:3.46M
Market Cap:348.00M
PE:-0.27
High:4.07
Open:3.94
Low:3.76
Close:3.80
52wk High:26.83
52wk Low:1.35
Shares:87.44M
Float Shares:69.55M
Volume Ratio:1.27
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.7566
EPS(LYR):-5.5878
ROE:-156.87%
ROA:-33.54%
PB:5.65
PE(LYR):-0.71

Loading ...

X4 Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 10

X4 Pharmaceuticals to Join Guggenheim Healthcare Innovation Conference

Reuters
·
Nov 06

X4 Pharma Q3 net loss narrows to $29.8 mln

Reuters
·
Nov 05

X4 Pharmaceuticals Reports $240 Million Financing and Shifts Focus to Phase 3 Chronic Neutropenia Trial

Reuters
·
Nov 05

X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Nov 05

X4 Pharmaceuticals Raises $155.3 Million in Public Offering

Reuters
·
Oct 28

X4 Pharmaceuticals Executive Chairman Adam R. Craig Reports Acquisition of Common Shares

Reuters
·
Oct 28

BUZZ-U.S. STOCKS ON THE MOVE-Cipher Mining, Kura, GrafTech

Reuters
·
Oct 24

X4 Pharmaceuticals Prices $135 Million Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Oct 24

X4 Pharmaceuticals Inc - Prices Public Offering at $2.90 per Share

THOMSON REUTERS
·
Oct 24

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

THOMSON REUTERS
·
Oct 24

BRIEF-X4 Pharmaceuticals Announces Proposed Underwritten Public Offering

Reuters
·
Oct 24

X4 Pharmaceuticals Inc - Proceeds to Fund Phase 3 Development of Mavorixafor

THOMSON REUTERS
·
Oct 24

X4 Pharmaceuticals announces restructuring, 50% reduction in workforce

TIPRANKS
·
Sep 17

X4 Pharmaceuticals - John Volpone Appointed COO in Addition to Current Role as President

THOMSON REUTERS
·
Sep 17

X4 Pharmaceuticals: as Part of Workforce Reduction, Mary Dibiase, Chief Operating Officer Will Be Exiting Co

THOMSON REUTERS
·
Sep 17

X4 Pharmaceuticals Inc - to Cut Workforce by 50%, Save $13 Mln Annually

THOMSON REUTERS
·
Sep 17

X4 Pharmaceuticals Inc - Three Executives to Exit X4 Pharmaceuticals

THOMSON REUTERS
·
Sep 17

Press Release: X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation

Dow Jones
·
Sep 17

BRIEF-X4 Pharmaceuticals Files For Offering Of Up To 59.9 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing

Reuters
·
Sep 11